The Regulation of Non-Invasive Prenatal Testing (NIPT) in France: Continuity and Changes in the Development of Prenatal Testing - Sciences de la vie - Ethique Accéder directement au contenu
Article Dans Une Revue OBM Genetics Année : 2022

The Regulation of Non-Invasive Prenatal Testing (NIPT) in France: Continuity and Changes in the Development of Prenatal Testing

Résumé

This article examines the regulation of the screening of fetal abnormalities in France before and after the implementation of the new technique of non-invasive prenatal testing (NIPT) in 2013. In addition, this article evaluates the effectiveness of the regulatory framework in addressing the ethical and social issues raised by this technique from a legal and sociological perspective. The analysis reveals that the regulations, consistent with that applied to other prenatal screening techniques, fail to take proper account of the following problems posed by NIPT: the continuing increase in the number of abnormalities detected in fetuses, the context of mounting pressure from the manufacturers, and the challenges involved in providing pregnant women with quality information that preserves their reproductive autonomy.
Fichier principal
Vignette du fichier
The Regulation of Non.pdf (801.92 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03907770 , version 1 (20-12-2022)

Identifiants

Citer

Carine Vassy, Christine Noiville, Laurence Brunet. The Regulation of Non-Invasive Prenatal Testing (NIPT) in France: Continuity and Changes in the Development of Prenatal Testing. OBM Genetics, 2022, 6 (Issue 1), ⟨10.21926/obm.genet.2201149⟩. ⟨hal-03907770⟩
30 Consultations
189 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More